MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase
about
Statin Use in Prostate Cancer: An UpdateMitochondria, cholesterol and cancer cell metabolismA novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosisSGF29 and Sry pathway in hepatocarcinogenesisMYC and metabolism on the path to cancerNonalcoholic fatty liver disease: new treatmentsMYC activation is a hallmark of cancer initiation and maintenanceRole of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)Xmrk, kras and myc transgenic zebrafish liver cancer models share molecular signatures with subsets of human hepatocellular carcinomaSREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinomaInactivation of MYC reverses tumorigenesis.Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem CellsSimvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancerConcurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma.A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide.Effects of statins on the risk of hepatocellular carcinomaChemopreventive strategies in hepatocellular carcinomaRepublished: Non-alcoholic fatty liver disease: a practical approach to treatment.Chemically induced mouse liver tumors are resistant to treatment with atorvastatin.Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancerStatins Attenuate Helicobacter pylori CagA Translocation and Reduce Incidence of Gastric Cancer: In Vitro and Population-Based Case-Control StudiesSystematic review with network meta-analysis: statins and risk of hepatocellular carcinomaStatin-Based Palliative Therapy for Hepatocellular CarcinomaRNAi silencing of c-Myc inhibits cell migration, invasion, and proliferation in HepG2 human hepatocellular carcinoma cell line: c-Myc silencing in hepatocellular carcinoma cellThe HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancerEffect of pravastatin on the survival of patients with advanced gastric cancer.Krüppel-like factor 2 promotes cell proliferation in hepatocellular carcinoma through up-regulation of c-myc.Meta-analysis of studies using statins as a reducer for primary liver cancer risk.Cancer prevention and therapy through the modulation of the tumor microenvironment.Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal CancerRegulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patientsDo statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis B?In vivo Reprogramming of Cancer Metabolism by MYC.Targeting tumor cell metabolism with statins.Potential for statins in the chemoprevention and management of hepatocellular carcinoma.Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin.Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention.Statin therapy in patients with cirrhosis.
P2860
Q26738631-74288726-B680-44AE-893F-D4A9614008D2Q26741708-86283025-05B7-4BCB-AB5D-A32AB38856A4Q26774351-8428BCF4-9112-4A64-9FB4-D44C406B7243Q26795760-8D0B01D7-65B3-4D1E-B580-B241E6208D60Q26798086-47382572-AD17-438D-8F35-F526BE942948Q27021161-CA218AAD-20C7-47ED-968C-571DF10F3D10Q27026026-0FBFF2B2-060D-442B-8765-5C9E1EE7EC8BQ28394917-D870D3A1-4B25-4F7B-8C9F-DE25AF7F9A68Q28540910-F2E1BC0B-DA3E-418C-8B23-064368EF397EQ33755503-AD9DFE18-CE7B-4737-8891-D1B58F290C45Q33784668-C0D608CE-6CB3-4A57-895D-E3682F229BFCQ33872400-4F94BD33-6B62-4E8F-B378-B08F016CB75DQ34017200-73442717-37F0-4E3E-AC5A-19D15C167FF7Q34770140-862CAB13-CEC2-44C2-A397-AB7D1F4B6F90Q34793715-CE649174-B7CB-40DC-B094-F866152286B9Q34997752-97E6D583-3418-496B-83A2-9F2C54596644Q35101365-3021011F-6590-4F32-8C05-79EB669CDD4FQ35135556-10A63CB3-9994-4267-B6F3-CF958D26AC6CQ35335391-9C90801C-A351-4D65-BEDD-A996988ABAD1Q35740123-6A2EF54B-36F1-4866-A95B-19959CBF66D6Q35885119-5C16E60E-71E4-4E1E-A9E7-2C3D1634625EQ35946029-835BA430-B693-4828-BF02-B3B87811500AQ36206887-B4D39F4A-14F9-483D-A528-1169F37DFD63Q36690321-9C0FEEC4-D69F-48FA-A7C5-301B6B019691Q36729573-A62C4665-9514-4C7B-8F72-C293BADF696EQ36782447-33E697B1-4DC7-4754-98D6-7CE9C284CF63Q36843752-E3EDB5A9-213E-4E01-8222-B996F78BDA19Q36919251-48B3A13D-3CC6-4E3C-806F-7E66CB58E064Q37058267-2A5BC856-7A8D-4EBE-B258-8F3C5710EDDFQ37221691-879AACCC-D6B9-4E38-9BCA-ADA7401CF3EDQ37248887-7780EB8E-5E73-469D-B440-75B28037616DQ37256889-E0360B35-0779-4907-9217-7D2FE2CD7570Q37584603-3CA9B0A4-CAFE-4160-A500-87B35204936CQ37746816-30FD7FD4-C658-4E2D-A2CB-C02563DA0182Q37981833-C182F642-3ED3-421F-B013-04CCD0B9D3FDQ38030991-14F8596C-6F6B-4C59-AEC6-7A1BEBCE9D80Q38147841-6E725146-6FBA-40AC-8F02-57C7E98B9BC0Q38519928-8A573A2C-A0EB-40D8-9230-F0A9D299D745Q38584060-2768F266-9367-44E1-A56D-A7DF5E712FD6Q38608978-F70F386C-978D-41C0-B41D-60B62E044655
P2860
MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
MYC phosphorylation, activatio ...... regulated by HMG-CoA reductase
@ast
MYC phosphorylation, activatio ...... regulated by HMG-CoA reductase
@en
MYC phosphorylation, activatio ...... regulated by HMG-CoA reductase
@nl
type
label
MYC phosphorylation, activatio ...... regulated by HMG-CoA reductase
@ast
MYC phosphorylation, activatio ...... regulated by HMG-CoA reductase
@en
MYC phosphorylation, activatio ...... regulated by HMG-CoA reductase
@nl
prefLabel
MYC phosphorylation, activatio ...... regulated by HMG-CoA reductase
@ast
MYC phosphorylation, activatio ...... regulated by HMG-CoA reductase
@en
MYC phosphorylation, activatio ...... regulated by HMG-CoA reductase
@nl
P2093
P2860
P1433
P1476
MYC phosphorylation, activatio ...... regulated by HMG-CoA reductase
@en
P2093
Aleksey Yevtodiyenko
David I Bellovin
Dean W Felsher
Julia Arzeno
Qiwei Yang
Sanjiv Sam Gambhir
Zhongwei Cao
P2860
P304
P356
10.1158/0008-5472.CAN-10-3367
P407
P577
2011-01-24T00:00:00Z